Fear Questionnaire (FQ)

Overview

The Fear Questionnaire (FQ) is one of the most widely recognized and extensively validated self-report instruments for assessing phobic symptoms and avoidance behaviors associated with anxiety disorders. Developed by Marks and Mathews (1979), the FQ was designed to provide a rapid yet reliable evaluation of the severity of phobic symptoms in both clinical and research settings. The questionnaire primarily assesses three major domains of fear—agoraphobia, social phobia, and blood/injury phobia—while also evaluating the overall functional impairment caused by these fears in daily life. Owing to its strong psychometric properties and ease of administration, the FQ has become a standard instrument in clinical psychology, psychiatry, cognitive-behavioral therapy (CBT), and anxiety research.

Objective

The primary objective of the Fear Questionnaire (FQ) is to provide an objective assessment of the intensity, frequency, and functional impact of phobic fears that interfere with an individual’s social, occupational, and personal functioning. The instrument supports the identification of anxiety disorders, assists clinical decision-making, and enables the monitoring of therapeutic outcomes over time.

Specifically, the FQ is designed to:

  • Assess the severity of phobic symptoms and avoidance behaviors.
  • Evaluate agoraphobia, social phobia, and blood/injury phobia.
  • Measure the functional impairment associated with anxiety-related fears.
  • Support the diagnosis and treatment planning of anxiety disorders.
  • Monitor symptom changes following psychological or pharmacological interventions.

Scale Structure

The Fear Questionnaire consists of a series of self-report items that assess both the intensity of fear and the degree of avoidance across a variety of anxiety-provoking situations. Participants rate their experiences using a standardized response scale, allowing quantitative measurement of phobic symptom severity.

The instrument is organized around three principal domains:

  • Agoraphobia, assessing fears related to public places, travel, or situations from which escape may be difficult.
  • Social Phobia, evaluating fears associated with social interactions and situations involving scrutiny or evaluation by others.
  • Blood/Injury Phobia, measuring fear responses to blood, injections, injuries, or medical procedures.

In addition to subscale scores, the FQ provides an overall index of phobic symptom severity and associated functional impairment.

Applications

The FQ is extensively used in clinical psychology, psychiatry, behavioral medicine, cognitive-behavioral therapy, and epidemiological research. It serves as an important screening and outcome measure for individuals with anxiety disorders, particularly those presenting with specific phobias, agoraphobia, or social anxiety disorder.

In research, the questionnaire is frequently employed to investigate the prevalence and severity of phobic symptoms, compare clinical and non-clinical populations, evaluate treatment efficacy, and examine associations between phobic symptoms and broader psychological constructs such as depression, quality of life, and emotional functioning.

Scoring and Psychometric Evaluation

Participants rate the degree of fear or avoidance experienced in each situation using a standardized response scale. Individual item scores are summed to generate subscale scores and an overall FQ score, with higher scores indicating greater severity of phobic symptoms and increased functional impairment. Interpretation follows the guidelines established by the scale developers or population-specific normative data.

The psychometric evaluation of the FQ typically includes analyses of internal consistency (Cronbach’s α), exploratory and confirmatory factor analyses (EFA/CFA) to examine construct validity, and correlation analyses with established measures of anxiety, depression, and quality of life to support convergent validity. The instrument is also widely used to evaluate changes in symptom severity before and after therapeutic interventions.

Interpretation

Higher FQ scores indicate more severe phobic symptoms, greater avoidance of anxiety-provoking situations, and increased interference with daily functioning. Elevated scores may reflect clinically significant anxiety requiring further psychological assessment or intervention, whereas lower scores suggest fewer fear-related difficulties and better psychosocial adjustment. The FQ is particularly valuable for monitoring treatment response, enabling clinicians to objectively assess improvements following cognitive-behavioral therapy, exposure-based interventions, or pharmacological treatment.

References

Cox, B. J., Parker, J. D. A., & Swinson, R. P. (1996). Confirmatory Factor Analysis of the Fear Questionnaire in Panic Disorder with Agoraphobia: Evidence for a Three-Factor Model. Behaviour Research and Therapy, 34(8), 689–693.

Marks, I. M., & Mathews, A. M. (1979). Brief Standard Self-Rating for Phobic Patients. Behaviour Research and Therapy, 17(3), 263–267.

Oei, T. P. S., & Moylan, A. (1994). The Fear Questionnaire: A Review. Journal of Behavior Therapy and Experimental Psychiatry, 25(4), 337–346.